Development of capsid-based vaccines and potential for multivalent vaccines.
Human monoclonal antibodies that block glycan binding as immunotherapeutic agents.
Viral protease and polymerase as targets for drug discovery.
Interferons and inhibitors of host cell factors as antivirals.